Eprosartan Explained

Eprosartan, sold under the brand name Teveten among others, is an angiotensin II receptor antagonist used for the treatment of high blood pressure.^[1]

Eprosartan is sometimes paired with hydrochlorothiazide.^[2]

As with other angiotensin II receptor antagonists, eprosartan is generally better tolerated than enalapril (an ACE inhibitor), especially among the elderly.^[3]

History

The compound came into the Abbott Laboratories cardiovascular pipeline with its acquisition of Kos Pharmaceuticals in 2006, which had licensed it, along with "a range of hypertensive treatments", from the Biovail Corporation.^[4]

Notes and References

1. Web site: Eprosartan mesylate- eprosartan mesylate tablet, film coated . DailyMed . 7 June 2023.
2. Web site: Teveten HCT- eprosartan mesylate and hydrochlorothiazide tablet . DailyMed . 3 January 2012 . 7 June 2023.
3. Ruilope L, Jäger B, Prichard B . Eprosartan versus enalapril in elderly patients with hypertension: a double-blind, randomized trial . Blood Press. . 10 . 4 . 223–9 . 2001 . 11800061 . 10.1080/08037050152669747. 13063704 . free .
4. Anon., 2006, Abbott Laboratories: Kos Pharmaceuticals a wise buy, Datamonitor ResearchStore (online), November 8, 2006, see http://www.datamonitor.com/store/News/abbott_laboratories_kos_pharmaceuticals_a_wise_buy?productid=0BE8B1AB-14F9-4B92-99D2-80E8DC7ECA16, accessed 29 January 2015.